Align Technology Beats Q1 Estimates, Posts Record Invisalign Shipments, Holds Full‑Year Outlook

* Quarter at a glance Align posted $1.04 billion in total revenue, up 5.4% YoY, and GAAP EPS of $1.57, topping Street forecasts by roughly 6 cents. The headline driver was Clear Aligner revenue, which rose 7.4% YoY to $856 million on a 6.7% volume increase. Imaging Systems and CAD/CAM Services, while down 12.1% sequentially, still managed a modest 0.9% YoY gain thanks to iTero Lumina full‑system sales and a shift toward leasing and Certified Pre‑Owned units.

* Margin dynamics GAAP gross margin slipped to 70.8% (non‑GAAP 71.8%), a 0.3‑0.4‑point drag from foreign‑exchange headwinds. Operating margin fell to 13.6% GAAP (non‑GAAP 21.5%) as the company absorbed the same FX impact and a higher proportion of lower‑priced scanner configurations. The gap between GAAP and non‑GAAP operating margins—driven by the exclusion of stock‑based compensation and other adjustments—remains a focal point for analysts monitoring cost discipline.

* Segment divergence - Clear Aligner: Record shipments of 685.7 k cases (+6.7% YoY) were powered by double‑digit growth in EMEA, APAC and LATAM, while North America held steady. Orthodontist shipments rose 7.4%, GP dentist shipments 5.6%, with teen/kid volume up 4.8% and adult volume up 7.8%. The mix shift toward higher‑priced adult cases helped lift average selling price, reinforcing the 7.4% revenue gain. - Imaging Systems & CAD/CAM: Revenue of $184.1 million fell sharply quarter‑over‑quarter, reflecting the typical capital‑equipment seasonality. Nevertheless, the segment posted a 0.9% YoY increase, buoyed by iTero Lumina full‑system sales, services revenue, and a growing Certified Pre‑Owned pipeline. The strategic push toward leasing and rentals is intended to smooth the seasonal troughs.

* Capital allocation and balance‑sheet strength Align completed a $200 million share repurchase (≈1.4 million shares at $143.85) and still has $800 million of authorization left under its $1 billion program. Management announced an additional $200 million buyback to commence May 1, signaling confidence in cash generation. With $1.06 billion in cash and a $300 million revolving credit facility, the company is well‑positioned to fund its digital platform investments and international expansion.

* Geopolitical and regulatory backdrop A February Supreme Court ruling eliminated the IEEPA tariffs that had threatened the supply chain. The subsequent temporary Section 122 tariffs, effective Feb 24, are expected to be immaterial. Align noted an immaterial impact from the Middle‑East conflict in Q1 but has baked a “prudent assumption of some demand pressure” into its Q2 outlook.

* Guidance outlook Management reaffirmed its FY 2026 revenue growth target of 3%–4% YoY and mid‑single‑digit Clear Aligner volume growth. Q2 revenue is projected at $1.04 billion–$1.06 billion, implying a 3%–5% YoY increase. GAAP operating margin is expected to rise to 16.4%, while non‑GAAP margin stays near 21.5%. The company assumes foreign‑exchange benefits will moderate to roughly 100 bps for the remainder of the year.

* Market reaction Shares edged up 0.63% to $178.40 in early trading, outpacing the S&P 500’s 0.02% decline, suggesting investors welcomed the beat and the unchanged guidance. The stock remains near the upper‑mid portion of its 52‑week range (65%) with a neutral RSI of 54, indicating room for further upside if the international growth trajectory accelerates.

Bottom line Align’s Q1 performance underscores the resilience of its core Clear Aligner franchise and the early traction of the iTero Lumina ecosystem. While seasonal softness in imaging drags short‑term margins, the company’s disciplined capital allocation, robust balance sheet, and reaffirmed full‑year outlook provide a solid platform for continued growth, especially as foreign‑exchange headwinds ease and tariff uncertainties recede.